Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: dalroi who wrote (91)	6/11/2001 1:30:07 PM
From: tuck	Read Replies (1) \| Respond to of 1005

>>now taking a snop on curn<< My command of Flemish stops at "snop," stefaan, so I'm not sure what you should drink on this occasion. Since CURN is a GI company, a case of Pepto-Bismal seems appropriate to me. DPII very near target level for BLUE HP and Trickle and me, all ready to pounce at $5.25. Further thoughts on therapeutic companies in lock-up hell, posters and lurkers? Getting ready to investigate Peter's suggestions of POZN and PTIE. If they are looking good -- and knowing Peter, they are -- BLUE HP wants to be ready to buy when the pain of 2nd Q warnings crescendos. Seems like the right companies to have under those circumstances. And if we're early, the obvious choice is again CURN. All based on their products, you understand. Coming soon, the stefaan/tuck update on the INGN/Aventis deal. Cheers, Tuck